IRCT20210715051901N1招募中3 期
The effect of Atomoxetine on Cognitive Function of Inpatient and Outpatient Multiple Sclerosis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 52
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Diagnosis of Multiple Sclerosis based on McDonald's criteria
- •Age between 18 to 55 years
- •Testable Measurable Cognitive impairment (MACFIMS) attributed to Multiple Sclerosis
排除标准
- •Continued use of Stimulant
- •Clinical relapse of Multiple Sclerosis with in 60 days of screening
- •Changes in the treatment of Multiple Sclerosis within 90 days of screening
- •Existence of any underlying factor and disease that causes dementia and cognitive impairment
- •Proof of moderate to severe depression with a Beck's test
- •Contraindications to the use of Atomoxetine
- •Confirmation of cognitive impairment related to Multiple Sclerosis with McFimes test
研究者
相似试验
暂停
不适用
Effects of atomoxetine on cognitive functions in normal subjects using fMRIHealthy adultsJPRN-UMIN000012947ippon Medical School25
招募中
3 期
The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia PatientsSchizophreniaIRCT20211219053452N1Arak University of Medical Sciences40
招募中
2 期
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
尚未招募
3 期
Atomoxetine for cognitive impairment in Behcet's diseaseBehcet's diseaseIRCT20211206053288N1Tehran University of Medical Sciences40
已完成
3 期
Study of therapeutic effects of Atomoxtein in reducing the symptoms of patients with recurrent vasovagal syncopeIRCT20180125038507N1Tehran University of Medical Sciences50